IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FRANCESCHINI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.145
NA - Nord America 8.698
AS - Asia 8.599
SA - Sud America 851
AF - Africa 134
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 5
Totale 29.469
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.457
GB - Regno Unito 4.268
SG - Singapore 2.662
CN - Cina 2.604
IT - Italia 1.637
DE - Germania 1.170
RU - Federazione Russa 1.058
SE - Svezia 990
HK - Hong Kong 735
BR - Brasile 579
TR - Turchia 527
IN - India 452
FR - Francia 423
VN - Vietnam 420
KR - Corea 389
IE - Irlanda 330
UA - Ucraina 298
NL - Olanda 277
FI - Finlandia 249
BD - Bangladesh 229
EU - Europa 205
CO - Colombia 122
GR - Grecia 119
JP - Giappone 119
CA - Canada 118
ID - Indonesia 115
PH - Filippine 64
MX - Messico 62
AR - Argentina 46
ES - Italia 46
IQ - Iraq 44
PL - Polonia 44
DK - Danimarca 43
AT - Austria 34
TH - Thailandia 34
AU - Australia 33
BE - Belgio 33
SA - Arabia Saudita 33
CL - Cile 24
CH - Svizzera 23
PK - Pakistan 22
UZ - Uzbekistan 22
ZA - Sudafrica 20
PE - Perù 19
TW - Taiwan 17
VE - Venezuela 17
CI - Costa d'Avorio 16
CR - Costa Rica 15
EG - Egitto 15
RO - Romania 15
EC - Ecuador 14
CZ - Repubblica Ceca 13
IR - Iran 13
MA - Marocco 13
NO - Norvegia 13
PY - Paraguay 13
JO - Giordania 12
KE - Kenya 12
IL - Israele 11
TN - Tunisia 10
MY - Malesia 9
RE - Reunion 9
UY - Uruguay 9
HN - Honduras 8
HU - Ungheria 8
KW - Kuwait 8
DZ - Algeria 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
AZ - Azerbaigian 6
ET - Etiopia 6
GT - Guatemala 6
HR - Croazia 6
NP - Nepal 6
PA - Panama 6
BG - Bulgaria 5
JM - Giamaica 5
MD - Moldavia 5
MN - Mongolia 5
NG - Nigeria 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
GH - Ghana 4
KG - Kirghizistan 4
LV - Lettonia 4
OM - Oman 4
PS - Palestinian Territory 4
SC - Seychelles 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BB - Barbados 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
IS - Islanda 3
KZ - Kazakistan 3
LB - Libano 3
LK - Sri Lanka 3
NI - Nicaragua 3
Totale 29.623
Salva come PNG Salva come JPEG
Città #
Southend 4.008
Singapore 1.563
Hong Kong 700
Chandler 675
Seattle 651
Ashburn 611
Beijing 540
San Jose 504
Milan 442
Princeton 431
Wilmington 378
Council Bluffs 337
Dublin 325
Redmond 270
Fairfield 267
Ann Arbor 249
Dallas 232
Nanjing 229
Jacksonville 199
Lauterbourg 171
Sakarya 171
Bengaluru 167
Mountain View 158
Woodbridge 154
Los Angeles 144
Hanover 138
Moscow 135
Boardman 132
Dearborn 131
Santa Clara 127
Houston 125
Des Moines 124
Guangzhou 124
Buffalo 119
Frankfurt am Main 118
Ho Chi Minh City 102
New York 96
Shanghai 96
Grafing 95
Athens 93
Hanoi 91
Redwood City 86
Shenyang 81
Jinan 80
Cambridge 78
Berlin 75
Bogotá 72
The Dalles 71
Serra 70
Tokyo 69
Columbus 68
Andover 64
Somerville 64
Tianjin 64
Jakarta 62
Nanchang 58
Phoenix 58
Hebei 57
Hefei 56
Toronto 56
Helsinki 49
São Paulo 49
Rome 48
Cangzhou 47
Changsha 46
Eitensheim 45
Shenzhen 45
Dong Ket 37
San Diego 33
Zhengzhou 33
Kiez 32
Munich 32
Hangzhou 31
Ningbo 31
Seoul 29
Bitonto 27
Brussels 26
Yubileyny 26
Fuzhou 24
Jiaxing 23
Lanzhou 23
Ponte San Pietro 23
Warsaw 23
Kunming 21
Turin 21
Bühl 20
Washington 20
Baghdad 19
Chicago 19
Sunnyvale 18
Belo Horizonte 17
Medford 17
Saint Petersburg 17
Tashkent 17
Falls Church 16
Hamburg 16
Auburn Hills 15
Naples 15
Abidjan 14
Amsterdam 14
Totale 17.789
Salva come PNG Salva come JPEG
Nome #
Complete and partial LCAT deficiency are differentially associated with atherosclerosis 488
Functional Lecithin : Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans 440
Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein 397
Cardiovascular status of carriers of the apolipoprotein A-I-Milano mutant - The Limone sul Garda study 396
Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I 387
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation 386
Deficit di lecitina:colesterolo aciltransferasi: dalla genetica alla terapia 341
Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function 339
Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome 315
Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides 309
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux 308
Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays 284
Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant 281
Beta2-adrenergic activity modulates vascular tone regulation in lecithin : cholesterol acyltransferase knockout mice 267
A model structure for the heterodimer apoA-IMilano-apoA-II supports its peculiar susceptibility to proteolysis 254
Lipoprotein X causes renal disease in LCAT deficiency 252
Characterization of in vivo activity of a novel Lecithin:cholesterol acyltransferase inhibitor 249
Normal endothelial function in carriers of the apolipoprotein A-IMilano mutant despite low HDL-cholesterol levels 248
Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients 248
Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits 246
eNOS activation by HDL is impaired in genetic CETP deficiency 232
Le basi farmacologiche della terapia 231
Colesterolo HDL e aterosclerosi carotidea 228
Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia 227
Inhibition of MMP-2 activation and release as a novel mechanism for HDL-induced cardioprotection 221
LCAT e spessore medio intimale carotideo in individui europei ad alto rischio cardiovascolare 221
Acquired lecithin :cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease 219
The impact of lecithin: cholesterolacyltransferase on endothelial function: study on a genetically modified model 217
Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL 212
Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia 204
Size is a major determinant of dissociation and denaturation behaviour of reconstituted high-density lipoproteins 203
ALTERATIONS IN HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS DURING POSTPRANDIAL LIPIDEMIA INDUCED BY FAT WITH AND WITHOUT ETHANOL 202
Farmacoterapia cardiovascolare 201
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families 200
Protective effects of HDL against ischemia/reperfusion injury 198
High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release 194
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family 190
Normal endothelial function in carriers of the apolipoprotein A-1milano mutant despite low HDL-cholesterol levels 189
Genetic variants of group A apolipoproteins. Rapid methods for screening and characterization without ultracentrifugation 187
Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury 186
Controllo farmacologico della lesione aterosclerotica : terapia delle dislipidemie 182
Vasculoprotective function of HDL from CETP-deficient subjects 180
AIMILANO APOPROTEIN IDENTIFICATION OF THE COMPLETE KINDRED AND EVIDENCE OF A DOMINANT GENETIC TRANSMISSION 179
Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome 179
INHIBITION OF ANTIPYRINE METABOLISM BY LOW-DOSE CONTRACEPTIVES WITH GESTODENE AND DESOGESTREL 178
The biochemical and cardiovascular consequences of LCAT deficiency 178
Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency 176
Endothelial protection by high-density lipoproteins 175
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene 175
APHERETIC TREATMENT OF SEVERE FAMILIAL HYPERCHOLESTEROLEMIA - COMPARISON OF DEXTRAN SULFATE CELLULOSE AND DOUBLE MEMBRANE FILTRATION METHODS FOR LOW-DENSITY LIPOPROTEIN REMOVAL 173
Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injury 171
High density lipoproteins inhibit oxidative stress-induced prostate cancer cell proliferation 171
Raising HDL cholesterol for cardiovascular disease prevention : is this still feasible? 170
Role of LCAT in HDL remodeling : investigation of LCAT deficiency states 170
Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations 170
Disposition of metformin (N,N-dimethylbiguanide) in man 170
Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients 169
Endothelial protection by high-density lipoproteins: from bench to bedside 169
Activity profile of gemfibrozil on the major plasma lipoprotein parameters 169
Characterization of Three Kindreds With Familial Combined Hypolipidemia Caused by Loss-of-Function Mutations of ANGPTL3 168
Functional LCAT is not required for macrophage cholesterol efflux to human serum 167
Structure, function and amyloidogenic propensity of apolipoprotein A-I 167
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 167
High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli 166
Structural features and dynamics properties of human apolipoprotein A-I in a model of synthetic HDL 166
APOLIPOPROTEIN AIMILANO - DISULFIDE-LINKED DIMERS INCREASE HIGH-DENSITY-LIPOPROTEIN STABILITY AND HINDER PARTICLE INTERCONVERSION IN CARRIER PLASMA 166
HDL and atherosclerosis : insights from inherited HDL disorders 166
Role of LCAT in atherosclerosis 166
APOLIPOPROTEIN A-IMILANO - CORRELATION BETWEEN HIGH-DENSITY-LIPOPROTEIN SUBCLASS DISTRIBUTION AND TRIGLYCERIDEMIA 165
Pharmacological studies on tiadenol in type IV patients. Evidence for a mechanism of action different from other lipid-lowering drugs 164
Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL 161
ALTERATIONS IN THE HDL SYSTEM AFTER RAPID PLASMA-CHOLESTEROL REDUCTION BY LDL-APHERESIS 161
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients 161
OMEGA-3-FATTY-ACIDS SELECTIVELY RAISE HIGH-DENSITY LIPOPROTEIN-2 LEVELS IN HEALTHY-VOLUNTEERS 160
A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins 159
Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases 158
Structure and function of the apoA-IV T347S and Q360H common variants 158
Mechanisms of high-density lipoprotein reduction after probucol treatment: Changes in plasma cholesterol esterification/transfer and lipase-activities 158
Structural features and dynamics properties of human apolipoprotein A-I in a model of synthetic HDL 157
Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk 157
Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux 156
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia 156
An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia 155
The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction 155
Plasma cholesteryl ester transfer protein (Cetp) and carotid intima-media thickness in european indivduals at high cardiovascular risk 152
LIPOPROTEIN STRUCTURE IN MALE-SUBJECTS DURING IN-VIVO LIPOLYSIS - EFFECT OF AN ANTI-LIPOLYTIC TREATMENT WITH ACIPIMOX 152
CHANGES IN HIGH-DENSITY LIPOPROTEIN SUBFRACTION DISTRIBUTION AND INCREASED CHOLESTERYL ESTER TRANSFER AFTER PROBUCOL 151
Off-target effects of thrombolytic drugs : apolipoprotein A-I proteolysis by alteplase and tenecteplase 151
IMMUNOCHEMICAL CHARACTERIZATION OF 6 MONOCLONAL-ANTIBODIES TO HUMAN APOLIPOPROTEIN-A-I - EPITOPE MAPPING AND EXPRESSION 150
Severe HDL deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphoma 149
Increased cholesterol efflux potential of sera from ApoA-I-Milano carriers and transgenic mice 147
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro) : a case-control study 147
NORMAL ENDOTHELlAL FUNCTION DESPlTE LOW HDL-CHOLESTEROL LEVELS IN CARRIERS OF THE APOLIPOPROTEIN A-IMitano MUTANT 145
Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer 144
Synthetic HDL as a new treatment for atherosclerosis regression : has the time come? 143
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 141
Role of human apolipoproteins in cell cholesterol efflux: Studies with transgenic mice 141
Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levels 141
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux 141
CETP levels rather than polymorphisms as markers of coronary risk: healthy athlete with high HDL-C and coronary disease—effectiveness of probucol 140
Totale 20.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021812 0 0 0 0 0 0 0 0 0 0 629 183
2021/20222.539 268 135 191 106 287 164 130 154 200 267 262 375
2022/20232.560 363 174 186 328 319 514 52 153 266 31 122 52
2023/20241.498 68 173 79 98 351 76 37 96 28 94 179 219
2024/20253.294 136 302 61 391 199 190 146 489 131 213 308 728
2025/20267.192 658 325 781 571 817 565 783 522 1.023 600 547 0
Totale 31.150